Categories: Manufacturers (D)

Enal Drugs Pvt Limited, D-33,34,35, Phase-I, IDA, Jeedimetla, Hyderabad -500055 AP,India

Company Name : Enal Drugs Pvt Limited

Address : D-33,34,35, Phase-I, IDA, Jeedimetla, Hyderabad -500055 AP, India

Tel No: 91-40- 44753636, 91-40-23193623

Email : enaldrugs@satyam.net.in, mktg@enaldrugs.com

Website : http://www.enaldrugs.com/

Company Profile

Enal Drugs Private Limited,an ISO 9001 : 2000 certified company, specializes in developing and producing anti ulcerative drugs, their intermediates, other active pharmaceutical ingredients (APIs) and intermediates. The project implementation commenced in the year 1990. Experimental batches in pilot plant were undertaken and commercial production started in the year 1996.

The promoters are first generation entrepreneurs with high technical qualifications, professional experience and leadership qualities team spirit and confidence to make this activity a successful business venture.

In the field of exports , Enal Drugs Private Ltd. enjoys a considerable reputation and export is the key thrust area of the company and is given maximum attention. The countries to which Enal Drugs Private Ltd. exports its products include Europe, Asia, Africa & South American countries.

The company is professionally managed having its corporate head quarters and works strategically situated in Hyderabad city, the heart of bulk drug manufacturing activity in India.

The administration, marketing, sales, purchase, finance & accounts divisions are housed in the manufacturing site.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

4 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

5 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

5 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

6 days ago